Are haemoglobin levels adequate in patients with chronic kidney disease (CKD) stage 2-4?
暂无分享,去创建一个
[1] L. McMahon,et al. KHA‐CARI guideline: Biochemical and haematological targets: Haemoglobin concentrations in patients using erythropoietin‐stimulating agents , 2012, Nephrology.
[2] Michèle Kessler,et al. Chronic kidney disease: appropriateness of therapeutic management and associated factors in the AVENIR study. , 2009, Journal of evaluation in clinical practice.
[3] L. McMahon. The CARI guidelines. Biochemical and haematological targets. Haemoglobin. , 2008, Nephrology.
[4] S. Johnson,et al. THE TECHNOLOGY BEHIND THE IMPROVEMENT IN ANAEMIA MANAGEMENT , 2006 .
[5] M. Zhan,et al. Survival Benefit of Recombinant Human Erythropoietin Administration prior to Onset of End-Stage Renal Disease: Variations across Surrogates for Quality of Care and Time , 2005, Nephron Clinical Practice.
[6] F. Locatelli,et al. Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[7] A. Collins. Anaemia management prior to dialysis: cardiovascular and cost-benefit observations. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[8] B. Astor,et al. Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988-1994). , 2002, Archives of internal medicine.
[9] T. Connor,et al. Renal handling of calcium and phosphate during mineralocorticoid "escape" in man. , 1972, Kidney international.